Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor ...(.com ...),Health

(Date:1/7/2009)...Research Shows Moms Seek Quality Online Tools , ... , Academy of General Dentistry Creates Comprehen...e-USNewswire/ -- Everyone knows that Moms are th...lds today. So it,s no wonder that, when it comes ... "Mother knows best." But until now, busy Moms we...

(Date:1/7/2009)...teenage boys don,t seem to be as susceptible, stud...Day News) -- Teenage girls who spend more than two... the Web or text-messaging are less likely to be p...Interestingly, boys who were part of the same stud... said lead author Louise Hardy, a postdoctoral fel...

(Date:1/7/2009)...HAT: , The Sixth International Chronic Total Occl...ng state-of-the-art technologies, research finding...hat are essential for interventional cardiologists...oronary occlusions. The conference will include pr... sessions, and numerous thematically organized liv...

(Date:1/7/2009)...ulsbo, WA January 7, 2009 Human calmodulin-like ...g breast, thyroid, prostate, kidney, and skin. The... a highly specific expression. Gaining an understa...al cells and its possible downregulation (or lack ...able marker in early detection of oral cancer. A n...

...wo new drugs on the Pharmaceutical Benefits Scheme...atment from October.// According to Health Minist...vemir and Lantus will be subsidized from October 1...r the next three years. These drugs have several ...

...rina, the American Academy of Pediatrics (AAP) is ...s to prepare// for potential natural and other dis... on children. Children are especially vulnerable ...commends that parents discuss possible disaster pl...

...ut 5 million adult Americans have moderate or seve...according to a Mayo Clinic study// published onlin...usly the main cause of valve diseases and was a ma...ddle of the 20th century, rheumatic fever is not a...

...ia appears to have met with unprecedented success.... of more than 2,000// children aged four to 12. T...ram lighter than those in a control group of child...al weight loss of one kilogram is not much, but he...

(Date:1/7/2009)..., BEIJING, Jan. 7 Tiantan Puhua H...hua.com ), the worldwide leader in using stem cell...ounced today six new globally experienced addition...ntly expand the hospital,s treatment capabilities ...ents. The six senior doctors include the distingui...

(Date:1/6/2009)..., NEW YORK, Jan. 6 The...t $2.7 million to four industry research teams for... for Parkinson,s disease. , , The funding was a...pment Initiative. This program, first launched in...rts on Parkinson,s research. TDI is part of MJFF...

(Date:1/5/2009)..., SAN DIEGO, Jan. 5 Cylene Pharma...Phase I clinical trial of its oral CK2 protein kin...solid tumors, Castleman,s disease, or multiple mye...ating trial are determination of safety, tolerance...propriate dose for Phase II trials. In addition, m...

(Date:12/29/2008)..., BETHESDA, Md., Dec. 29 /PRNewswire-USNewswire/ ...Human Research Protection was announced today by D...the Health Improvement Institute. , , The winn...xas M.D. Anderson Cancer Center -- for its best..." This program provides for 1) enhanced human sub...

...un 1, 2007 - A therapeutic,vaccine developed by th...mises new hope for cancer patients. The results of...resented to an,international audience at the Annua...Oncology (ASCO) in Chicago, USA. ASCO is the,most ...ialists,world-wide., The active substance VPM4001,...

... 1, 2007 - OXiGENE, Inc.,(NASDAQ: OXGN, XSSE: OXGN...loping novel therapeutics to treat cancer and eye,...bstracts in the,2007 Annual Meeting program distri...American Society of Clinical Oncology (ASCO),in Ch...st time full data from a,randomized Phase II trial...

Our popular Back-Aid Apron now comes standard with an improved Universal Back-Saver Belt that has firmer side supports to take more weight off your shoulders! Waist-hugging belt and back shoulder str

Hip-hugging design transfers weight from shoulders to the hips. Crisscross shoulder design provides snug and comfortable upper torso fit while preventing apron from slipping off shoulders.

Multispot HIV-1/HIV-2 is a rapid indirect EIA using recombinant and peptide antigens for simultaneous detection and differentiation of anti-HIV-1 and anti-HIV-2 antibodies in human serum or plasma.

Complete cytology platform.